Ross Douglas
Ross Douglas
Verified email at
Cited by
Cited by
Active migration and passive transport of malaria parasites
RG Douglas, R Amino, P Sinnis, F Frischknecht
Trends in parasitology 31 (8), 357-362, 2015
Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme
WL Kröger, RG Douglas, HG O’Neill, V Dive, ED Sturrock
Biochemistry 48 (35), 8405-8412, 2009
Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors
RG Douglas, RK Sharma, G Masuyer, L Lubbe, I Zamora, KR Acharya, ...
Clinical science 126 (4), 305-313, 2014
Inter-subunit interactions drive divergent dynamics in mammalian and Plasmodium actin filaments
RG Douglas, P Nandekar, JE Aktories, H Kumar, R Weber, JM Sattler, ...
PLoS biology 16 (7), e2005345, 2018
Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme
KM Larmuth, G Masuyer, RG Douglas, SL Schwager, KR Acharya, ...
The FEBS Journal 283 (6), 1060-1076, 2016
Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme
G Masuyer, RG Douglas, ED Sturrock, KR Acharya
Scientific reports 5, 13742, 2015
A novel angiotensin I-converting enzyme mutation (S333W) impairs N-domain enzymatic cleavage of the anti-fibrotic peptide, AcSDKP
SM Danilov, MS Wade, SL Schwager, RG Douglas, AB Nesterovitch, ...
PLoS One 9 (2), e88001, 2014
Screening for potential prophylactics targeting sporozoite motility through the skin
RG Douglas, M Reinig, M Neale, F Frischknecht
Malaria journal 17 (1), 319, 2018
A small mitochondrial protein present in myzozoans is essential for malaria transmission
D Klug, GR Mair, F Frischknecht, RG Douglas
Open biology 6 (4), 160034, 2016
The dynamic nonprime binding of sampatrilat to the C-domain of angiotensin-converting enzyme
RK Sharma, M Espinoza-Moraga, H Poblete, RG Douglas, ED Sturrock, ...
Journal of Chemical Information and Modeling 56 (12), 2486-2494, 2016
New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme
RK Sharma, RG Douglas, S Louw, K Chibale, ED Sturrock
Biological Chemistry 393 (6), 485-493, 2012
Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor design.
RG Douglas, MR Ehlers, ED Sturrock
Clinical & Experimental Pharmacology & Physiology 40 (8), 2013
Divergent Plasmodium actin residues are essential for filament localization, mosquito salivary gland invasion and malaria transmission
M Yee, T Walther, F Frischknecht, RG Douglas
PLoS pathogens 18 (8), e1010779, 2022
Vasopeptidase inhibition—Solving the cardiovascular puzzle?
RG Douglas, MRW Ehlers, ED Sturrock
Drugs of the Future 36 (1), 33, 2011
Characterization of angiotensin I-converting enzyme N-domain selectivity using positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides
PA Bersanetti, RA Sabatini, BS Matos, RG Douglas, A Nchinda, ...
Biological Chemistry 393 (12), 1547-1554, 2012
The 2001 uses of GFP: A review of “Illuminating Disease”
RG Douglas, F Frischknecht
Structure-based design of domain-selective angiotensin-converting enzyme inhibitors
RG Douglas, ED Sturrock
Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional …, 2012
Angiotensin I-converting enzyme
RG Douglas, ED Sturrock
Encyclopedia of Metalloproteins, 63-68, 2013
Significance of active site residues in the n-domain selectivity of angiotensin-converting enzyme
RG Douglas
The system can't perform the operation now. Try again later.
Articles 1–19